By expenditures
| Name | Title | Type |
|---|---|---|
| Jose A. Segarra | Business Administrator | Auditee |
| John Mooney | Partner | Auditee |
| Andrew Kucinski | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 374759 | 2025 | 2025-12-15 | NISIVOCCIA LLP | $1.60M |
| 333875 | 2024 | 2024-12-19 | Nisivoccia LLP | $3.66M |
| 311648 | 2023 | 2024-07-03 | Nisivoccia LLP | $2.09M |
| 309758 | 2023 | 2024-06-25 | Nisivoccia LLP | $2.09M |
| 12180 | 2023 | 2024-01-18 | Nisivoccia LLP | $2.09M |
| 35395 | 2022 | 2023-01-04 | Nisivoccia LLP | $1.21M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 374759 | 2025 | 2025-12-15 | 1164877 | 2025-002 | Material Weakness | Yes | L |
| 333875 | 2024 | 2024-12-19 | 1092518 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 1092517 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 1092516 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 1092515 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 516076 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 516075 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 516074 | 2024-002 | Significant Deficiency | Yes | L |
| 333875 | 2024 | 2024-12-19 | 516073 | 2024-002 | Significant Deficiency | Yes | L |
| 311648 | 2023 | 2024-07-03 | 982927 | 2023-002 | Significant Deficiency | - | BCIL |
| 311648 | 2023 | 2024-07-03 | 982926 | 2023-002 | Significant Deficiency | - | BCIL |
| 311648 | 2023 | 2024-07-03 | 982925 | 2023-002 | Significant Deficiency | - | BCIL |
| 311648 | 2023 | 2024-07-03 | 406485 | 2023-002 | Significant Deficiency | - | BCIL |
| 311648 | 2023 | 2024-07-03 | 406484 | 2023-002 | Significant Deficiency | - | BCIL |
| 311648 | 2023 | 2024-07-03 | 406483 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 978291 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 978290 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 978289 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 401849 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 401848 | 2023-002 | Significant Deficiency | - | BCIL |
| 309758 | 2023 | 2024-06-25 | 401847 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 585339 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 585338 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 585337 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 8897 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 8896 | 2023-002 | Significant Deficiency | - | BCIL |
| 12180 | 2023 | 2024-01-18 | 8895 | 2023-002 | Significant Deficiency | - | BCIL |